Q32 Bio (QTTB) Capital Expenditures Growth (3y) (2020 - 2026)
Q32 Bio (QTTB) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
227.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
227.11% |
| Dec 31, 2025 |
374.42% |
| Jun 30, 2025 |
-30.14% |
| Mar 31, 2025 |
61.17% |
| Dec 31, 2024 |
-65.66% |
| Sep 30, 2024 |
85.66% |
| Jun 30, 2024 |
32.16% |
| Mar 31, 2024 |
-47.98% |
| Sep 30, 2023 |
-47.62% |
| Jun 30, 2023 |
-55.83% |
| Mar 31, 2023 |
-76.89% |
| Dec 31, 2022 |
26.82% |
| Sep 30, 2022 |
26.00% |
| Jun 30, 2022 |
-52.23% |
| Mar 31, 2022 |
-77.63% |
| Dec 31, 2021 |
-76.49% |
| Sep 30, 2021 |
-26.25% |
| Jun 30, 2021 |
-29.54% |
| Mar 31, 2021 |
211.62% |
| Dec 31, 2020 |
-114.89% |
